Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability

A series of twenty-two quinazolinamine derivatives showing potent inhibitory activities on breast cancer resistance protein (BCRP) and p-glycoprotein (P-gp) were synthesized. A cyclopropyl-containing quinazolinamine 22 was identified as a dual BCRP and P-gp inhibitor, while azide-containing quinazol...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Chao-Yun, Teng, Qiu-Xu, Murakami, Megumi, Ambudkar, Suresh V., Chen, Zhe-Sheng, Korlipara, Vijaya L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953095/
https://www.ncbi.nlm.nih.gov/pubmed/36830622
http://dx.doi.org/10.3390/biom13020253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953095/
https://www.ncbi.nlm.nih.gov/pubmed/36830622
http://dx.doi.org/10.3390/biom13020253

Ejemplares similares